Skip to Content
You are currently on the new version of our website. Access the old version .

12 Results Found

  • Article
  • Open Access
8 Citations
4,990 Views
11 Pages

Formulation and In Vitro Evaluation of Pellets Containing Sulfasalazine and Caffeine to Verify Ileo-Colonic Drug Delivery

  • Annemarie Broesder,
  • Said Y. Bircan,
  • Anneko B. de Waard,
  • Anko C. Eissens and ,
  • Henderik W. Frijlink and
  • Wouter L. J. Hinrichs
  • + 1 author+ 0 author

The ColoPulse coating is a pH-dependent coating that can be used to target drug release to the ileo-colonic region. ColoPulse coated tablets and capsules have demonstrated their targeting capabilities in vivo in more than 100 volunteers and patients....

(This article belongs to the Section Biopharmaceutics)
  • Article
  • Open Access
5 Citations
3,537 Views
20 Pages

Formulation of a 3D Printed Biopharmaceutical: The Development of an Alkaline Phosphatase Containing Tablet with Ileo-Colonic Release Profile to Treat Ulcerative Colitis

  • Khanh T. T. Nguyen,
  • Franca F. M. Heijningen,
  • Daan Zillen,
  • Kjeld J. C. van Bommel and ,
  • Renz J. van Ee,
  • Henderik W. Frijlink and
  • Wouter L. J. Hinrichs
  • + 2 authors+ 0 author

Powder bed printing is a 3D-printing process that creates freeform geometries from powders, with increasing traction for personalized medicine potential. Little is known about its applications for biopharmaceuticals. In this study, the production of...

  • Article
  • Open Access
21 Citations
6,437 Views
19 Pages

Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process

  • Bahez Gareb,
  • Silke Posthumus,
  • Max Beugeling,
  • Pauline Koopmans and ,
  • Daan J. Touw,
  • Gerard Dijkstra,
  • Jos G.W. Kosterink and
  • Henderik W. Frijlink
  • + 3 authors+ 0 author

Infliximab (IFX) is an intravenously administered monoclonal antibody antagonizing the effects of tumor necrosis factor-alpha (TNF) systemically and is efficacious in the treatment of inflammatory bowel disease (IBD). However, studies suggest that th...

  • Article
  • Open Access
2,045 Views
15 Pages

Surface Engineering Methods for Powder Bed Printed Tablets to Optimize External Smoothness and Facilitate the Application of Different Coatings

  • Khanh T. T. Nguyen,
  • Daan Zillen,
  • Franca F. M. van Heijningen,
  • Kjeld J. C. van Bommel and ,
  • Renz J. van Ee,
  • Henderik W. Frijlink and
  • Wouter L. J. Hinrichs
  • + 2 authors+ 0 author

In a previous attempt to achieve ileo-colonic targeting of bovine intestinal alkaline phosphatase (BIAP), we applied a pH-dependent coating, the ColoPulse coating, directly on powder bed printed (PBP) tablets. However, the high surface roughness nece...

(This article belongs to the Section Pharmaceutical Technology, Manufacturing and Devices)
  • Article
  • Open Access
14 Citations
5,366 Views
16 Pages

Ileo-Colon Targeting of the Poorly Water-Soluble Drug Celecoxib Using a pH-Dependent Coating in Combination with Self-Emulsifying Drug Delivery or Solid Dispersion Systems

  • Annemarie Broesder,
  • Julia M. E. Berends,
  • Sophie M. Scheepers,
  • Duong N. Nguyen and ,
  • Henderik W. Frijlink and
  • Wouter L. J. Hinrichs
  • + 1 author+ 0 author

Targeting celecoxib to the ileo-colonic region could be beneficial for the treatment and prevention of colon cancer. Ileo-colonic targeting can be achieved by using pH-dependent coating systems such as ColoPulse. Celecoxib has poor aqueous solubility...

(This article belongs to the Special Issue Colon-Targeted Drug Delivery)
  • Article
  • Open Access
6 Citations
3,909 Views
20 Pages

Capsules with Ileocolonic-Targeted Release of Vitamin B2, B3, and C (ColoVit) Intended for Optimization of Gut Health: Development and Validation of the Production Process

  • Aisha A. Ahmed,
  • Antonius T. Otten,
  • Bahez Gareb,
  • Judith E. Huijmans and ,
  • Anko C. Eissens,
  • Ateequr Rehman,
  • Gerard Dijkstra,
  • Jos G. W. Kosterink,
  • Henderik W. Frijlink and
  • Reinout C. A. Schellekens
  • + 5 authors+ 0 author

The ileocolonic-targeted delivery of vitamins can establish beneficial alterations in gut microbial composition. Here, we describe the development of capsules containing riboflavin, nicotinic acid, and ascorbic acid covered with a pH-sensitive coatin...

(This article belongs to the Collection Drug Delivery in The Netherlands)
  • Article
  • Open Access
23 Citations
6,210 Views
17 Pages

Ileocolonic-Targeted JAK Inhibitor: A Safer and More Effective Treatment for Inflammatory Bowel Disease

  • Vipul Yadav,
  • Aileen House,
  • Silvia Matiz,
  • Laura E. McCoubrey and ,
  • Kimberly A. Bettano,
  • Leena Bhave,
  • Meiyao Wang,
  • Peter Fan,
  • Siqun Zhou and
  • Hongshi Yu
  • + 12 authors+ 7 authors

Janus kinase (JAK) inhibitors, such as tofacitinib (Xeljanz) and filgotinib (Jyseleca), have been approved for treatment of ulcerative colitis with several other JAK inhibitors in late-stage clinical trials for inflammatory bowel disease (IBD). Despi...

  • Article
  • Open Access
8 Citations
2,363 Views
14 Pages

2 June 2015

This research work aims to determine the pharmacokinetic parameters and in vitro-in vivo correlation of the selected ileocolonic-targeted coated mini-tablet filled capsule formulation of naproxen. The pure suspension and coated mini-tablet filled cap...

  • Case Report
  • Open Access
349 Views
12 Pages

1 September 2026

Background and Clinical Significance: Adult intussusception is rare, accounting for approximately 5% of all intussusceptions and 1–5% of adult bowel obstructions, whereas the ileo–ileo–colic subtype is exceptionally uncommon. We rep...

  • Review
  • Open Access
10 Citations
4,167 Views
16 Pages

Therapeutic Drug Monitoring of Biologics in IBD: Essentials for the Surgical Patient

  • Rodrigo Bremer Nones,
  • Phillip R. Fleshner,
  • Natalia Sousa Freitas Queiroz,
  • Adam S. Cheifetz and ,
  • Antonino Spinelli,
  • Silvio Danese,
  • Laurent Peyrin-Biroulet,
  • Konstantinos Papamichael and
  • Paulo Gustavo Kotze
  • + 4 authors+ 0 author

29 November 2021

Despite significant development in the pharmacological treatment of inflammatory bowel diseases (IBD) along with the evolution of therapeutic targets and treatment strategies, a significant subset of patients still requires surgery during the course...

(This article belongs to the Special Issue New Frontiers in Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases)
  • Article
  • Open Access
14 Citations
6,804 Views
20 Pages

The aim of the present study was to develop an alternative process to spray granulation in order to prepare high loaded spherical nicotinamide (NAM) pellets by wet extrusion and spheronisation. Therefore, a quality by design approach was implemented...

(This article belongs to the Special Issue Pharmaceutical Applications of Hot-melt Extrusion)
  • Perspective
  • Open Access
3 Citations
3,579 Views
15 Pages

Upper Gastrointestinal Crohn’s Disease: Shedding Light on the Obscure L4 Classification Meaning

  • Francesca Lusetti,
  • Cristina Bezzio,
  • Alice De Bernardi,
  • Michele Puricelli and ,
  • Gianpiero Manes and
  • Simone Saibeni
  • + 1 author+ 0 author

20 November 2025

Background/Objectives: Upper gastrointestinal Crohn’s disease (UGI-CD) is inconsistently defined and often underrecognized, obscuring epidemiology, complicating diagnosis, and delaying tailored care. The absence of a unified, operational definition w...

(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)